Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
182.35 USD   +0.48%
04:24pInsider Sell: Moderna
MT
04:17pInsider Sell: Moderna
MT
04:34aCornell University : Experimental vaccines offer long-term protection against severe COVID
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Deutsche Bank Upgrades Moderna to Buy From Hold

09/07/2022 | 04:42pm EST


ę MT Newswires 2022
All news about MODERNA, INC.
04:24pInsider Sell: Moderna
MT
04:17pInsider Sell: Moderna
MT
04:34aCornell University : Experimental vaccines offer long-term protection against severe COVID
AQ
12/01Transcript : Moderna, Inc. Presents at Piper Sandler 34th Annual Healthcare C..
CI
11/30Moderna exec says COVID trials improved diversity recruiting
RE
11/30Insider Sell: Moderna
MT
11/30Insider Sell: Moderna
MT
11/30Britain is little better prepared for future pandemics - Former UK vaccine chief
RE
11/28Insider Sell: Moderna
MT
11/28Insider Sell: Moderna
MT
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 19 089 M - -
Net income 2022 8 897 M - -
Net cash 2022 12 022 M - -
P/E ratio 2022 8,41x
Yield 2022 -
Capitalization 69 721 M 69 721 M -
EV / Sales 2022 3,02x
EV / Sales 2023 6,38x
Nbr of Employees 2 700
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 181,48 $
Average target price 211,25 $
Spread / Average Target 16,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
James M. Mock Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-28.55%67 581
IQVIA HOLDINGS INC.-21.83%40 495
LONZA GROUP AG-33.17%38 281
ALNYLAM PHARMACEUTICALS, INC.29.88%27 139
SEAGEN INC.-21.72%22 538
CELLTRION, INC.-9.85%18 418